SS
DRUG

SBI Securities’s Bright Minds Biosciences DRUG Stock Holding History

SBI Securities’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351 Hold
5
– – ﹤0.01% 3156
2026
Q1 		$365 Hold
5
– – ﹤0.01% 3007
2025
Q4 		$390 Sell
5
-51
-91% -$3.41K ﹤0.01% 2966
2025
Q3 		$3.4K Buy
56
+1
+2% +$39 ﹤0.01% 2216
2025
Q2 		$1.44K Hold
55
– – ﹤0.01% 2528
2025
Q1 		$1.98K Hold
55
– – ﹤0.01% 2293
2024
Q4 		$1.98K Buy
+55
New +$1.94K ﹤0.01% 2321

Other funds holding DRUG

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

SBI Securities's DRUG Position: Q2 2026 in Review

SBI Securities held its Bright Minds Biosciences (DRUG) position steady in Q2 2026 at 5 shares worth $351. The position accounts for ﹤0.01% of the portfolio, ranked #3156.

SBI Securities first reported a position in DRUG in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.4K in Q3 2025. 11 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • SBI Securities held 5 shares of Bright Minds Biosciences worth $351 as of Q2 2026.
  • SBI Securities left its Bright Minds Biosciences share count unchanged in Q2 2026.
  • Bright Minds Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3156 holding.
  • SBI Securities first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Bright Minds Biosciences position peaked at $3.4K in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.